Clinical trial NCT02459678 - References

Human Immunodeficiency Virus — ART Readiness in HIV-infected Pregnant Women

Citation(s)

•   Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach: 2010 Version
  Geneva: World Health Organization; 2010.
•   Assefa Y, Kiflie A, Tekle B, Mariam DH, Laga M, Van Damme W
  Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia. J Health Serv Res Policy. 2012 Jan;17(1):24-9. doi: 10.1258/jhsrp.2011.010135. Epub 2011 Nov 17.
•   Balfour L, Kowal J, Silverman A, Tasca GA, Angel JB, Macpherson PA, Garber G, Cooper CL, Cameron DW
  A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006 Oct;18(7):830-8.
•   Balfour L, Tasca GA, Kowal J, Corace K, Cooper CL, Angel JB, Garber G, Macpherson PA, Cameron DW
  Development and validation of the HIV Medication Readiness Scale. Assessment. 2007 Dec;14(4):408-16.
•   Bernard, H
  R., Research Methods in Anthropology. 1995, Walnut Creek Altamira Press 535.
•   Bicego G, Boerma JT, Ronsmans C
  The effect of AIDS on maternal mortality in Malawi and Zimbabwe. AIDS. 2002 May 3;16(7):1078-81.
•   Borghi J, Ensor T, Somanathan A, Lissner C, Mills A; Lancet Maternal Survival Series steering group
  Mobilising financial resources for maternal health. Lancet. 2006 Oct 21;368(9545):1457-65. Review.
•   Centers for Disease Control and Prevention (CDC)
  Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013 Mar 1;62(8):148-51.
•   Central Statistical Office, Demographic Health Survey
  2007: Lusaka.
•   Chi BH, Bolton-Moore C, Holmes CB
  Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS. 2013 Sep;8(5):498-503. doi: 10.1097/COH.0b013e3283637f7a. Review.
•   Chibwesha CJ, Giganti MJ, Putta N, Chintu N, Mulindwa J, Dorton BJ, Chi BH, Stringer JS, Stringer EM
  Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):224-8. doi: 10.1097/QAI.0b013e318229147e.
•   Cook PF, McCabe MM, Emiliozzi S, Pointer L
  Telephone nurse counseling improves HIV medication adherence: an effectiveness study. J Assoc Nurses AIDS Care. 2009 Jul-Aug;20(4):316-25. doi: 10.1016/j.jana.2009.02.008.
•   Ekirapa-Kiracho E, Waiswa P, Rahman MH, Makumbi F, Kiwanuka N, Okui O, Rutebemberwa E, Bua J, Mutebi A, Nalwadda G, Serwadda D, Pariyo GW, Peters DH
  Increasing access to institutional deliveries using demand and supply side incentives: early results from a quasi-experimental study. BMC Int Health Hum Rights. 2011 Mar 9;11 Suppl 1:S11. doi: 10.1186/1472-698X-11-S1-S11.
•   Enriquez M, Lackey NR, O'Connor MC, McKinsey DS
  Successful adherence after multiple HIV treatment failures. J Adv Nurs. 2004 Feb;45(4):438-46.
•   European Collaborative Study, Patel D, Cortina-Borja M, Thorne C, Newell ML
  Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis. 2007 Jun 15;44(12):1647-56. Epub 2007 May 2.
•   Fehr JS, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A, Bregenzer T, Vernazza P, Jäger H, Spirig R, Battegay M; Swiss HIV Cohort Study
  Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection. 2005 Aug;33(4):249-56.
•   Fernández MI, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J; Adolescent Medicine Trials Network (ATN)
  Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings. AIDS Care. 2011 Nov;23(11):1492-9. doi: 10.1080/09540121.2011.565020. Epub 2011 Jun 21.
•   Gerbert B, Bronstone A, Clanon K, Abercrombie P, Bangsberg D
  Combination antiretroviral therapy: health care providers confront emerging dilemmas. AIDS Care. 2000 Aug;12(4):409-21.
•   Government of the Republic of Zambia, Adult and Adolescent Antiretroviral Therapy Protocols, M
  o. Health, Editor. 2010: Lusaka.
•   Government of the Republic of Zambia, Lifelong Antiretroviral Drugs (ARV's) for all HIV positive Pregnant Women in Zambia, M
  o. Health, Editor. 2013: Lusaka.
•   Government of the Republic of Zambia, National Protocol Guidelines Integrated Prevention of Mother-to-Child Transmission of HIV/AIDS, M
  o. Health, Editor. 2008: Lusaka.
•   Grimes RM, Grimes DE
  Patient readiness to adhere to HAART. J Int Assoc Physicians AIDS Care (Chic). 2009 Nov-Dec;8(6):364-6. doi: 10.1177/1545109709351240.
•   Grimes RM, Grimes DE
  Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep. 2010 Nov;7(4):245-52. doi: 10.1007/s11904-010-0056-2. Review.
•   Johnson MO, Dilworth SE, Stephens E, Lum PJ, Neilands TB
  Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV. J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):469-71. doi: 10.1097/QAI.0b013e3182365671.
•   Johnson MO, Gamarel KE, Dawson Rose C
  Changing HIV treatment expectancies: a pilot study. AIDS Care. 2006 Aug;18(6):550-3.
•   Kalembo FW, Zgambo M, Mulaga AN, Yukai D, Ahmed NI
  Association between male partner involvement and the uptake of prevention of mother-to-child transmission of HIV (PMTCT) interventions in Mwanza district, Malawi: a retrospective cohort study. PLoS One. 2013 Jun 12;8(6):e66517. doi: 10.1371/journal.pone.0066517. Print 2013.
•   Konkle-Parker DJ
  A motivational intervention to improve adherence to treatment of chronic disease. J Am Acad Nurse Pract. 2001 Feb;13(2):61-8. Review.
•   Krueger, R
  and M. Casey, Focus Groups: A Practical Guide for Applied Research, 3rd edition. 2000, Thousand Oaks: Sage Publications.
•   Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, Thea DM
  Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission. AIDS. 2010 Jun 1;24(9):1374-7.
•   Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Kasonde P, Mwiya M, Tsai WY, Thea DM; Zambia Exclusive Breastfeeding Study (ZEBS)
  Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS One. 2009 Jun 26;4(6):e6059. doi: 10.1371/journal.pone.0006059.
•   Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW
  Predictors of medication adherence in high risk youth of color living with HIV. J Pediatr Psychol. 2010 Jul;35(6):593-601. doi: 10.1093/jpepsy/jsp080. Epub 2009 Sep 15.
•   Mazimba C, C
  W., , Kaseba C, Chi B, HIV-related maternal mortality in Lusaka, Zambia: 1993-2004, in 3rd IAS Conference on HIV Pathogenesis and Treatment: Rio de Janeiro, Brazil.
•   McIntyre J
  Maternal health and HIV. Reprod Health Matters. 2005 May;13(25):129-35.
•   Miles, M
  and A. Huberman, Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. 1994, Thousand Oaks: Sage Publications.
•   Millennium Development Goals Progress Report
  2011, Ministry of Finance and National Planning, UNDP: Lusaka.
•   Moodley J, Pattinson RC, Baxter C, Sibeko S, Abdool Karim Q
  Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG. 2011 Jan;118(2):219-25. doi: 10.1111/j.1471-0528.2010.02726.x. Epub 2010 Sep 24. Review.
•   Morgenstern TT, Grimes DE, Grimes RM
  Assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials. 2002 Mar-Apr;3(2):168-72.
•   Myer L, Zulliger R, Bekker LG, Abrams E
  Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study. BMC Pregnancy Childbirth. 2012 Sep 11;12:94. doi: 10.1186/1471-2393-12-94.
•   Naar-King S, Parsons JT, Murphy D, Kolmodin K, Harris DR; ATN 004 Protocol Team
  A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression. J Adolesc Health. 2010 May;46(5):422-8. doi: 10.1016/j.jadohealth.2009.11.198. Epub 2010 Feb 4.
•   Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, Mills EJ, Ho YS, Stringer JS, McIntyre JA, Mofenson LM
  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012 Oct 23;26(16):2039-52. doi: 10.1097/QAD.0b013e328359590f. Review.
•   National HIV/AIDS/STIs/TB Council, 2009 HIV Epidemiological Projections Report
  2009: Zambia.
•   Nordqvist O, Södergård B, Tully MP, Sönnerborg A, Lindblad AK
  Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns. 2006 Jul;62(1):21-30. Review.
•   Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ
  The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):194-201.
•   Perez F, Aung KD, Ndoro T, Engelsmann B, Dabis F
  Participation of traditional birth attendants in prevention of mother-to-child transmission of HIV services in two rural districts in Zimbabwe: a feasibility study. BMC Public Health. 2008 Dec 5;8:401. doi: 10.1186/1471-2458-8-401.
•   Republic of Zambia Ministry of Health, National Protocol Guidelines Integrated Prevention of Mother-to-Child Transmission of HIV, Directorate of Public Health and Research, Editor
  2010, Ministry of Health: Lusaka, Zambia.
•   Rodrigues R, Shet A, Antony J, Sidney K, Arumugam K, Krishnamurthy S, D'Souza G, DeCosta A
  Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One. 2012;7(8):e40723. doi: 10.1371/journal.pone.0040723. Epub 2012 Aug 27.
•   Schmidt JO, Ensor T, Hossain A, Khan S
  Vouchers as demand side financing instruments for health care: a review of the Bangladesh maternal voucher scheme. Health Policy. 2010 Jul;96(2):98-107. doi: 10.1016/j.healthpol.2010.01.008. Review.
•   Seidenberg P, Nicholson S, Schaefer M, Semrau K, Bweupe M, Masese N, Bonawitz R, Chitembo L, Goggin C, Thea DM
  Early infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results. Bull World Health Organ. 2012 May 1;90(5):348-56. doi: 10.2471/BLT.11.100032.
•   Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, Kiwanuka N, Lutalo T, Kigozi G, Li C, Meehan MP, Brahmbatt H, Wawer MJ
  Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS. 2000 Oct 20;14(15):2391-400.
•   Shaffer N, Abrams EJ, Becquet R
  Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS. 2014 Feb 20;28(4):599-601. doi: 10.1097/QAD.0000000000000144.
•   Stubbs BA, Micek MA, Pfeiffer JT, Montoya P, Gloyd S
  Treatment partners and adherence to HAART in Central Mozambique. AIDS Care. 2009 Nov;21(11):1412-9. doi: 10.1080/09540120902814395.
•   Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, Chirwa Z, Ng'ambi W, Bakali A, Phiri S, Myer L, Valeri F, Zwahlen M, Wandeler G, Keiser O
  Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS. 2014 Feb 20;28(4):589-598. doi: 10.1097/QAD.0000000000000143.
•   Tessema B, Biadglegne F, Mulu A, Getachew A, Emmrich F, Sack U
  Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther. 2010 Jan 14;7:2. doi: 10.1186/1742-6405-7-2.
•   Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, Scott JD, Stirratt MJ, Remien RH, Simoni JM, Nachega JB
  Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012 Jun 5;156(11):817-33, W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, W-292, W-293, W-294. doi: 10.7326/0003-4819-156-11-201206050-00419. Epub 2012 Mar 5.
•   Tremblay CL, Baril JG, Fletcher D, Kilby D, Macpherson P, Shafran SD, Tyndall MW
  Challenges in initiating antiretroviral therapy in 2010. Can J Infect Dis Med Microbiol. 2010 Aug;21 Suppl C:1C-15C.
•   UNAIDS
  HIV and AIDS estimates 2009. [cited 2011 April 11]; Available from: http://www.unaids.org/en/regionscountries/countries/zambia/.
•   Wagner G, Iguchi M, Schneider S, Scott J, Anderson D
  Placebo practice trials: a tool to assess and improve adherence readiness. HIV Clin Trials. 2002 Nov-Dec;3(6):475-81.
•   Wagner GJ, Goggin K, Remien RH, Rosen MI, Simoni J, Bangsberg DR, Liu H; MACH14 Investigators
  A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med. 2011 Dec;42(3):352-60. doi: 10.1007/s12160-011-9295-8.
•   Wagner GJ, Kanouse DE, Koegel P, Sullivan G
  Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004 May;16(4):501-6.
•   Webster PD, Sibanyoni M, Malekutu D, Mate KS, Venter WD, Barker PM, Moleko W
  Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa. BMJ Qual Saf. 2012 Apr;21(4):315-24. doi: 10.1136/bmjqs-2011-000381.
•   Weigel R, Hosseinipour MC, Feldacker C, Gareta D, Tweya H, Chiwoko J, Gumulira J, Kalulu M, Mofolo I, Kamanga E, Mwale G, Kadzakumanja A, Jere E, Phiri S
  Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi. Trop Med Int Health. 2012 Jun;17(6):751-9. doi: 10.1111/j.1365-3156.2012.02980.x. Epub 2012 Apr 5.
•   Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B
  HIV-related knowledge and adherence to HAART. AIDS Care. 2003 Oct;15(5):673-9.
•   Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ
  Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000 Jul;22(7):858-71.
•   Wolff B, Mbonye M, Coutinho A, Amuron B, Nkabala R, Jaffar S, Grosskurth H
  High levels of psychosocial readiness for ART in an African population at the onset of treatment. SAHARA J. 2009 Dec;6(4):188-94.
•   World Health Organization, Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, in HIV/AIDS Programme
  2012: Geneva.
•   Zambia National HIV/AIDS/STI/TB Council, Zambia HIV Prevention Response and Modes of Transmission Analysis
  2009.

ART Readiness in HIV-infected Pregnant Women: From Formative Qualitative Research to Individual Randomized Trial

Details for clinical trial NCT02459678